Skip to content

QHSLab, Inc.: 10-Q filed 2023-11-13

What QHSLab, Inc. reported in its quarterly report filed 2023-11-13 (fiscal Q3 2023): 35 published measures, 104 facts as tagged in accession 0001493152-23-040470.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-13
Fiscal period
fiscal Q3 2023
Accession
0001493152-23-040470 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All QHSLab, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-301,738,933USD
At 2022-12-311,957,453USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-302,038,413USD
At 2022-12-311,881,208USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-299,480USD
At 2023-06-30-217,037USD
At 2023-03-31-110,310USD
At 2022-12-3176,245USD
At 2022-09-30286,199USD
At 2022-06-30409,131USD
At 2022-03-31676,111USD
At 2021-12-31824,066USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-3050,240USD
At 2022-12-31178,694USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-82,443USD92
2023-01-01 to 2023-09-30-381,725USD273
2023-04-01 to 2023-06-30-106,727USD91
2023-01-01 to 2023-03-31-192,555USD90
2022-07-01 to 2022-09-30-310,115USD92
2022-01-01 to 2022-09-30-779,804USD273
2022-04-01 to 2022-06-30-279,385USD91
2022-01-01 to 2022-03-31-190,304USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-24,462USD273
2022-01-01 to 2022-09-30-281,205USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-07-01 to 2023-09-30336,407USD92
2023-01-01 to 2023-09-301,093,974USD273
2022-07-01 to 2022-09-30269,323USD92
2022-01-01 to 2022-09-30975,469USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-103,992USD273
2022-01-01 to 2022-09-30269,403USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-37,119USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-3,896,621USD
At 2022-12-31-3,514,896USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-309,315,508shares92
2023-01-01 to 2023-09-309,315,508shares273
2022-07-01 to 2022-09-309,068,225shares92
2022-01-01 to 2022-09-308,889,836shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-309,315,508shares92
2023-01-01 to 2023-09-309,315,508shares273
2022-07-01 to 2022-09-309,068,225shares92
2022-01-01 to 2022-09-308,889,836shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.01USD/shares92
2023-01-01 to 2023-09-30-0.04USD/shares273
2022-07-01 to 2022-09-30-0.03USD/shares92
2022-01-01 to 2022-09-30-0.09USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.01USD/shares92
2023-01-01 to 2023-09-30-0.04USD/shares273
2022-07-01 to 2022-09-30-0.03USD/shares92
2022-01-01 to 2022-09-30-0.09USD/shares273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-09-306,000USD273
2022-01-01 to 2022-09-3023,842USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-35,233USD92
2023-01-01 to 2023-09-30-191,747USD273
2022-07-01 to 2022-09-30-203,411USD92
2022-01-01 to 2022-09-30-414,838USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-30176,990USD
At 2022-12-31285,578USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-3048,581USD92
2023-01-01 to 2023-09-30192,268USD273
2022-07-01 to 2022-09-30106,704USD92
2022-01-01 to 2022-09-30362,946USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-302,038,413USD
At 2022-12-311,706,826USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-30220,237USD
At 2022-12-3185,743USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-09-301,450,248USD
At 2022-12-311,504,332USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-3083,550USD
At 2022-12-3147,734USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-30224,743USD92
2023-01-01 to 2023-09-30795,427USD273
2022-07-01 to 2022-09-30329,018USD92
2022-01-01 to 2022-09-30899,342USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-3038,954USD
At 2022-12-3151,840USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30189,510USD92
2023-01-01 to 2023-09-30603,680USD273
2022-07-01 to 2022-09-30125,607USD92
2022-01-01 to 2022-09-30484,504USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-30146,897USD92
2023-01-01 to 2023-09-30490,294USD273
2022-07-01 to 2022-09-30143,716USD92
2022-01-01 to 2022-09-30490,965USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-3045,419USD92
2023-01-01 to 2023-09-30169,489USD273
2022-07-01 to 2022-09-3048,405USD92
2022-01-01 to 2022-09-30135,998USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-309,315,508shares
At 2022-12-319,315,508shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-303,595,837USD
At 2022-12-313,589,837USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-3047,277USD92
2023-01-01 to 2023-09-30205,799USD273
2022-07-01 to 2022-09-30107,965USD92
2022-01-01 to 2022-09-30321,573USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-3036,930USD273
2022-01-01 to 2022-09-3055,939USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-09-3050,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-3041,808USD273
2022-01-01 to 2022-09-30-3,207USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-12,886USD273
2022-01-01 to 2022-09-3032,219USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30134,494USD273
2022-01-01 to 2022-09-30129,625USD273

Inspect the source

Entity
QHSLab, Inc. / CIK 0000856984
Captured
2026-09-19T15:10:28.069Z
SEC response SHA-256
567b88de3249cdc5207b56b3566b6abed1e619516b4e04d582aa059617ce6475

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000856984.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))